1)  anthracycline
蒽环抗癌药物
2)  anthracycline
蒽环
1.
Study on the Difference between Several Anthracycline Antibiotics Action with DNA by Spectroelectrochemistry;
蒽环类抗肿瘤抗生素与DNA作用差异性的光谱电化学研究
2.
~(99m)Tc-MIBI myocardial perfusion tomography for monitoring the anthracycline cardiotoxicity;
~(99m)Tc-MIBI心肌灌注断层显像监测蒽环类药物的心脏毒性
3.
Objective:To investigate the effect of fructose-1,6-diphosphato (FDP)on myocardial injure induced by anthracycline in children with acute leukemia.
目的：研究1,6-二磷酸果糖(FDP)对使用蒽环类化疗药致心肌损害的白血病患儿的疗效。
3)  Anthracycline
蒽环类
1.
Anthracyclines,paclitaxel and trastuzumab are cardiotoxic during and after the treatment of breast cancer.
在乳腺癌治疗中,蒽环类药物、紫杉类药物和靶向治疗药物曲妥单抗均具有心脏毒性,第三代芳香化酶抑制剂会增加冠状动脉粥样硬化性心脏病(冠心病)的风险,放疗也会引起心脏毒性。
2.
Objective To evaluate the efficacy and toxicity of combined chemotherapy of docetaxel(DOC) combined with cisplatin(DDP) for 28 patients with anthracycline-resistant advanced breast cancer(ABC).
目的观察泰索帝联合顺铂治疗蒽环类耐药性晚期转移性乳腺癌28例的疗效与毒副反应。
3.
Methods: Among 32 patients with advanced breast cancer 18 patients previously received chemotherapy based on anthracycline,while the others did not.
方法:晚期乳腺癌32例其中包括既往应用蒽环类药物治疗18例,非蒽环类药物化疗14例。
4)  Anthracycline
蒽环类药物
1.
In vitro study on Anthracycline-induced injury of cardiomyocyte H9c2;
蒽环类药物心肌损害的体外实验
2.
Recent advances of reactive oxygen species and cytotoxicity of anthracycline on leukemia cells;
蒽环类药物对白血病细胞的细胞毒作用与活性氧的关系研究进展
3.
Clinical Study of Shenmai injection treatment for patients with cardio-toxicity caused by anthracycline;
参麦注射液治疗蒽环类药物所致心脏毒性的临床研究
5)  anthracycline-resistant
蒽环类耐药
1.
Paclitaxel and cisplatin in treatment of anthracycline-resistant advanced breast carcinoma;
紫杉醇联合顺铂治疗30例蒽环类耐药性晚期乳腺癌的疗效分析
2.
Objective To evaluate the efficacy and toxicity of vinorelbine(NVB) plus cisplatin(DDP) in the treatment of anthracycline-resistant advanced breast cancer.
目的观察长春瑞滨(vinorelbine,NVB)联合顺铂(cisplatin,DDP)组成的NP方案治疗蒽环类耐药晚期乳腺癌患者的疗效和毒副反应。
6)  marcellomycin
蒽环类药物
1.
Objective To observe the heart protection effect of parenteral solution Shenqifuzheng in the chemotherapy with marcellomycin.
目的:观察参芪扶正液抗蒽环类药物化疗所致心脏毒性的作用。
参考词条
补充资料：氨基酸类抗癌药物
分子式：暂无
分子量：暂无
CAS号：暂无

性质：暂无

制备方法：暂无

用途：暂无

说明：补充资料仅用于学习参考，请勿用于其它任何用途。